Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Cash on Hand 2022–2025
Taysha Gene Therapies Inc. annual/quarterly cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Taysha Gene Therapies Inc. cash on hand for the quarter ending December 31, 2025 were 319.8M, a 129.99% increase year-over-year.
- Taysha Gene Therapies Inc. cash on hand for 2025 were 319.8M, a 129.99% increase from 2024.
- Taysha Gene Therapies Inc. cash on hand for 2024 were 139.0M, a 3.41% decrease from 2023.
- Taysha Gene Therapies Inc. cash on hand for 2023 were 143.9M, a 63.79% increase from 2022.
- Taysha Gene Therapies Inc. cash on hand for 2022 were 87.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Taysha Gene Therapies Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $320 |
| 2024 | $139 |
| 2023 | $144 |
| 2022 | $88 |
| Taysha Gene Therapies Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $320 |
| 2024-12-31 | $139 |
| 2023-12-31 | $144 |
| 2022-12-31 | $88 |
Taysha Gene Therapies Inc. Cash on Hand — FAQ
Taysha Gene Therapies Inc. (TSHA) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's cash on hand history?
The chart and table above show Taysha Gene Therapies Inc.'s cash on hand by year and by quarter, including the growth rate.